Anti-HLA class I antibody-mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cells

Human Immunology

Volumn 65, Issue 4, 2004, Pages 291-302

  Jin, Yi Ping ^a   Fishbein, Michael C ^a   Said, Jonathan W ^a   Jindra, Peter T ^a   Rajalingam, Raja ^a   Rozengurt, Enrique ^a   Reed, Elaine F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

endothelial cells; MHC; signal transduction; transplantation

Indexed keywords

HLA ANTIBODY; HLA CLASS 1 ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PHOSPHOTRANSFERASE; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE B; UNCLASSIFIED DRUG; VASCULOTROPIN; WORTMANNIN;

ANIMAL CELL; ARTICLE; BIOPSY TECHNIQUE; CELL ADHESION; CELL DEATH; CELL SURVIVAL; ENDOTHELIUM CELL; ENZYME ACTIVATION; HEART GRAFT; HEART MUSCLE BIOPSY; HISTOCOMPATIBILITY; HUMAN; HUMAN CELL; LIGATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TARGET CELL; UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; ANTIBODIES; BCL-ASSOCIATED DEATH PROTEIN; BCL-X PROTEIN; CARRIER PROTEINS; CELL LINE; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FOCAL ADHESION KINASE 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GRAFT REJECTION; HEART TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; UP-REGULATION;

EID: 2142724749     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2004.01.002     Document Type: Article

References (46)

1. Mauiyyedi S., Colvin R.B. Humoral rejection in kidney transplantation new concepts in diagnosis and treatment. Curr Opin Nephrol Hypertens. 11:2002;609
2. Joosten S.A., Van Kooten C., Paul L.C. Pathogenesis of chronic allograft rejection. Transpl Int. 16:2003;137
3. Paul L.C., Fellstrom B. Chronic vascular rejection of the heart and the kidney - have rational treatment options emerged? Transplantation. 53:1992;1169
4. Bian H., Harris P.E., Mulder A., Reed E.F. Anti-HLA antibody ligation to HLA class I molecules expressed by endothelial cells stimulates tyrosine phosphorylation, inositol phosphate generation, and proliferation. Hum Immunol. 53:1997;90
5. Bian H., Harris P.E., Reed E.F. Ligation of HLA class I molecules on smooth muscle cells with anti-HLA antibodies induces tyrosine phosphorylation, fibroblast growth factor receptor expression and cell proliferation. Int Immunol. 10:1998;1315
6. Bian H., Reed E.F. Alloantibody-mediated class I signal transduction in endothelial cells and smooth muscle cells enhancement by IFN-gamma and TNF-alpha. J Immunol. 163:1999;1010
7. Bian H., Reed E.F. Anti-HLA antibodies transduce proliferative signals in endothelial cells and smooth muscle cells. Transplant Proc. 31:1999;1924
8. Harris P.E., Bian H., Reed E.F. Induction of high affinity fibroblast growth factor receptor expression and proliferation in human endothelial cells by anti-HLA antibodies a possible mechanism for transplant atherosclerosis. J Immunol. 159:1997;5697
9. Jin Y.P., Singh R.P., Du Z.Y., Rajasekaran A.K., Rozengurt E., Reed E.F. Ligation of HLA class I molecules on endothelial cells induces phosphorylation of Src, paxillin and focal adhesion kinase in an actin dependent manner. J Immunol. 168:2002;5415
10. Schaller M.D. Biochemical signals and biological responses elicited by the focal adhesion kinase. Biochim Biophys Acta. 1540:2001;1
11. Michaels P.J., Espejo M.L., Kobashigawa J., Alejos J.C., Burch C., Takemoto S., Reed E.F., Fishbein M.C. Humoral rejection in cardiac transplantation risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. J Heart Lung Transplant. 22:2003;58
12. Coffer P.J., Jin J., Woodgett J.R. Protein kinase B (c-Akt) a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem J. 335:(Pt 1):1998;1
13. Brazil D.P., Hemmings B.A. Ten years of protein kinase B signalling a hard Akt to follow. Trends Biochem Sci. 26:2001;657
14. Datta S.R., Brunet A., Greenberg M.E. Cellular survival a play in three Akts. Genes Dev. 13:1999;2905
15. Kandel E.S., Hay N. The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp Cell Res. 253:1999;210
16. Owen J.D., Ruest P.J., Fry D.W., Hanks S.K. Induced focal adhesion kinase (FAK) expression in FAK-null cells enhances cell spreading and migration requiring both auto- and activation loop phosphorylation sites and inhibits adhesion-dependent tyrosine phosphorylation of Pyk2. Mol Cell Biol. 19:1999;4806
17. Salazar E.P., Rozengurt E. Src family kinases are required for integrin-mediated but not for G protein-coupled receptor stimulation of focal adhesion kinase autophosphorylation at Tyr-397. J Biol Chem. 276:2001;17788
18. Parsons J.T. Focal adhesion kinase the first ten years. J Cell Sci. 116:(Pt 8):2003;1409
19. Yano S., Tokumitsu H., Soderling T.R. Calcium promotes cell survival through CaM-K kinase activation of the protein-kinase-B pathway. Nature. 396:(6711):1998;584
20. Katso R., Okkenhaug K., Ahmadi K., White S., Timms J., Waterfield M.D. Cellular function of phosphoinositide 3-kinases implications for development, homeostasis, and cancer. Annu Rev Cell Dev Biol. 17:2001;615
21. Frisch S.M., Screaton R.A. Anoikis mechanisms. Curr Opin Cell Biol. 13:2001;555
22. Madge L.A., Pober J.S. A phosphatidylinositol 3-kinase/Akt pathway, activated by tumor necrosis factor or interleukin-1, inhibits apoptosis but does not activate NFkappaB in human endothelial cells. J Biol Chem. 275:2000;15458
23. Kim A.H., Khursigara G., Sun X., Franke T.F., Chao M.V. Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1. Mol Cell Biol. 21:2001;893
24. Kulik G., Klippel A., Weber M.J. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol Cell Biol. 17:1997;1595
25. Grad J.M., Zeng X.R., Boise L.H. Regulation of Bcl-xL a little bit of this and a little bit of STAT. Curr Opin Oncol. 12:2000;543
26. Skov S., Nielsen M., Bregenholt S., Odum N., Claesson M.H. Activation of Stat-3 is involved in the induction of apoptosis after ligation of major histocompatibility complex class I molecules on human Jurkat T cells. Blood. 91:1998;3566
27. Patel R., Terasaki P.I. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med. 280:1969;735
28. Bach F.H., Ferran C., Hechenleitner P., Mark W., Koyamada N., Miyatake T., Winkler H., Badrichani A., Candinas D., Hancock W.W. Accommodation of vascularized xenografts expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment. Nat Med. 3:1997;196
29. Hancock W.W., Buelow R., Sayegh M.H., Turka L.A. Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nat Med. 4:1998;1392
30. Contreras J.L., Bilbao G., Smyth C., Eckhoff D.E., Xiang X.L., Jenkins S., Cartner S., Curiel D.T., Thomas F.T., Thomas J.M. Gene transfer of the Bcl-2 gene confers cytoprotection to isolated adult porcine pancreatic islets exposed to xenoreactive antibodies and complement. Surgery. 130:2001;166
31. Badrichani A.Z., Stroka D.M., Bilbao G., Curiel D.T., Bach F.H., Ferran C. Bcl-2 and Bcl-XL serve an anti-inflammatory function in endothelial cells through inhibition of NF-kappaB. J Clin Invest. 103:1999;543
32. Ferran C., Stroka D.M., Badrichani A.Z., Cooper J.T., Wrighton C.J., Soares M., Grey S.T., Bach F.H. A20 inhibits NF-kappaB activation in endothelial cells without sensitizing to tumor necrosis factor-mediated apoptosis. Blood. 91:1998;2249
33. Brouard S., Otterbein L.E., Anrather J., Tobiasch E., Bach F.H., Choi A.M., Soares M.P. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med. 192:2000;1015
34. Katori M., Busuttil R.W., Kupiec-Weglinski J.W. Heme oxygenase-1 system in organ transplantation. Transplantation. 74:2002;905
35. Salama A.D., Delikouras A., Pusey C.D., Cook H.T., Bhangal G., Lechler R.I., Dorling A. Transplant accommodation in highly sensitized patients a potential role for Bcl-xL and alloantibody. Am J Transplant. 1:2001;260
36. Ratkovec R.M., Hammond E.H., O'Connell J.B., Bristow M.R., DeWitt C.W., Richenbacher W.E., Millar R.C., Renlund D.G. Outcome of cardiac transplant recipients with a positive donor-specific crossmatch - preliminary results with plasmapheresis. Transplantation. 54:1992;651
37. Pisani B.A., Mullen G.M., Malinowska K., Lawless C.E., Mendez J., Silver M.A., Radvany R., Robinson J.A. Plasmapheresis with intravenous immunoglobulin G is effective in patients with elevated panel reactive antibody prior to cardiac transplantation. J Heart Lung Transplant. 18:1999;701
38. Sonnenday C.J., Ratner L.E., Zachary A.A., Burdick J.F., Samaniego M.D., Kraus E., Warren D.S., Montgomery R.A. Preemptive therapy with plasmapheresis/intravenous immunoglobulin allows successful live donor renal transplantation in patients with a positive cross-match. Transplant Proc. 34:2002;1614
39. Alexandre G.P., De Bruyere M., Squifflet J.P., Moriau M., Latinne D., Pirson Y. Human ABO-incompatible living donor renal homografts. Neth J Med. 28:1985;231
40. Palmer A., Taube D., Welsh K., Bewick M., Gjorstrup P., Thick M. Removal of anti-HLA antibodies by extracorporeal immunoadsorption to enable renal transplantation. Lancet. 1:(8628):1989;10
41. Kupin W.L., Venkat K.K., Hayashi H., Mozes M.F., Oh H.K., Watt R. Removal of lymphocytotoxic antibodies by pretransplant immunoadsorption therapy in highly sensitized renal transplant recipients. Transplantation. 51:1991;324
42. Mendez R., Sakhrani L., Aswad S., Minasian R., Obispo E., Mendez R.G. Successful living-related ABO incompatible renal transplant using the BIOSYNSORB Immunoadsorption Column. Transplant Proc. 24:1992;1738
43. Ross C.N., Gaskin G., Gregor-Macgregor S., Patel A.A., Davey N.J., Lechler R.I., Williams G., Rees A.J., Pusey C.D. Renal transplantation following immunoadsorption in highly sensitized recipients. Transplantation. 55:1993;785
44. Reisaeter A.V., Leivestad T., Albrechtsen D., Holdaas H., Hartmann A., Sodal G., Flatmark A., Fauchald P. Pretransplant plasma exchange or immunoadsorption facilitates renal transplantation in immunized patients. Transplantation. 60:1995;242
45. Nath N., Bian H., Reed E.F., Chellappan S.P. HLA class I-mediated induction of cell proliferation involves cyclin E-mediated inactivation of Rb function and induction of E2F activity. J Immunol. 162:1999;5351
46. Maher P.A. Nuclear translocation of fibroblast growth factor (FGF) receptors in response to FGF-2. J Cell Biol. 134:1996;529